The success of Sildenafil initially sparked a boom for major pharmaceutical companies, nevertheless recent shifts present a uncertain scenario for investors. Lower-cost alternatives are reducing earnings, and https://orlandogayz709433.mdkblog.com/47327491/viagra-and-big-pharma-a-precarious-bet